Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jack Dean Insider Profile
4 Followers
Jack Dean, Director at PLx Pharma, holds 27.55K shares in Acurx Pharmaceuticals (Ticker: ACXP), holds 48.92K shares in PLx Pharma (Ticker: PLXPQ). Most recently, Jack Dean Bought ― shares of Acurx Pharmaceuticals on Jan 08, 2025 for an estimated value of 9.95K.
Profitable Transactions
3 out of 3 Profitable Transactions
Average Return
+21.90%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Jack Dean holds in companies
Most Profitable Insider Trade
Stock:
PLx Pharma
(PLXPQ)
(PLXPQ)
Rating:Informative Buy
Date:May 22, 2014 - May 22, 2015
Return:+37.00%
The most profitable trade made by Jack Dean
Jack Dean's Trading History
PLx Pharma
May 22, 2014
―
Informative Buy
27.00K
$489.17
Acurx Pharmaceuticals
Jan 08, 2025
Director
Informative Buy
9.95K
$24.32K
List of latest transactions for each holding click on a transaction to see Jack Dean's performance on stock
You May Also Like
Jack Dean insider profile FAQ
What is the percentage of profitable transactions made by Jack Dean?
The percentage of profitable transactions made by Jack Dean is 100%.
What is the average return per transaction made by Jack Dean?
The average return per transaction made by Jack Dean is 21.90%.
What stocks does Jack Dean hold?
Jack Dean holds: PLXPQ, ACXP stocks.
What was Jack Dean’s latest transaction?
Jack Dean latest transaction was an Informative Buy of $9.95K.
What was Jack Dean's most profitable transaction?
Jack Dean’s most profitable transaction was an Informative Buy of PLXPQ stock on May 22, 2014. The return on the trade was 37.00%.
What is Jack Dean's role in PLx Pharma?
Jack Dean's role in PLx Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.